In myasthenia gravis (MG), an autoimmune disorder characterized primarily by muscle weakness due to antibody-mediated neuromuscular junction disruption, autoantibodies targeting specific epitopes of HERV-K and HERV-W envelope proteins have been identified in patient serum samples [45]. Here, ERVW-1 is linked to myasthenia gravis.